<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

School of Medicine News and Stories

Diabetes

Research    Diabetes   

How a Smartphone App Can Help People With Diabetes Manage Their Condition and Avoid Certain Medications 

Can a smartphone app reduce the need for medication in patients with Type 2 diabetes? That’s what Marc Bonaca, MD, professor of cardiology in the University of Colorado School of Medicine, set out to discover.  


Author Greg Glasgow | Publish Date April 10, 2023
Full Story

Research    Community    Diabetes   

Can Taking the Stairs Help You Lose Weight? 

Audrey Bergouignan, PhD, isn’t looking for people with obesity to start running marathons. She just wants them to walk across the room. 


Author Greg Glasgow | Publish Date March 20, 2023
Full Story

Research    Diabetes    Pediatrics

CU School of Medicine Researcher Brews Up Study on Coffee’s Effects on Acute Kidney Injury

Can drinking coffee help stave off acute kidney injury? Potentially, says Kalie Tommerdahl, MD.


Author Greg Glasgow | Publish Date September 23, 2022
Full Story

Research    Diabetes   

CU School of Medicine a Site for Major Diabetes Medication Trial 

The University of Colorado School of Medicine was one of 36 study sites for a clinical trial that shows that diabetes drugs liraglutide and insulin glargine, when taken with metformin, allow patients to achieve and maintain their target blood levels for a longer time compared to two other commonly used diabetes medications.  


Author Greg Glasgow | Publish Date September 22, 2022
Full Story

Research    Community    Support    Diabetes   

Physical Activity Coaching Shows Benefits for People with Type 2 Diabetes

For some people with type 2 diabetes, the E word can evoke dread: exercise.


Author Rachel Sauer | Publish Date May 04, 2022
Full Story

Research    Diabetes    Obesity   

CU Researchers Identify New Method for Stimulating Signaling to Improve Metabolic Health and Possibly Treat Obesity

Following up on a 2018 study that identified an epigenetic modifier known as histone deacetylase 11 (HDAC11) as a potential therapeutic target for treating obesity and diabetes, researchers from the University of Colorado School of Medicine have published new research that finds HDAC11 regulates G protein-coupled receptors (GPCRs) called beta-adrenergic receptors (β-ARs).


Author Greg Glasgow | Publish Date February 11, 2022
Full Story

Research    Press Releases    Community    Diabetes

Planting the SEEDS to Connect Diabetes Patients With Devices That Help Them Manage Their Disease

As a nurse, researcher, and educator at the Barbara Davis Center for Diabetes at the University of Colorado School of Medicine for the past 17 years, Laurel Messer, PhD, has conducted clinical trials that brought devices to market to help diabetes patients monitor their blood sugar levels and administer insulin.


Author Greg Glasgow | Publish Date December 15, 2021
Full Story

Research    Community    Faculty    Diabetes

Research Finds Breath Ketone Analyzers May Detect Ketosis in People with Type I Diabetes

For people with type I diabetes, a build-up of blood acids called ketones can lead to a serious condition called diabetic ketoacidosis. This condition occurs when the body doesn’t have enough insulin to break down glucose, its usual energy source, and can lead to diabetic coma or even death.


Author Rachel Sauer | Publish Date November 30, 2021
Full Story

School of Medicine In the News

Arab American News

Dearborn native Ahmad Hider making his mark on the world of medicine

news outletArab American News
Publish DateJuly 11, 2024

Dearborn native Ahmad Hider is leading an accomplished and decorated academic and professional career.

More News
Femteck Insider

PCOS: Emerging Research and the Ongoing Search for Answers

news outletFemteck Insider
Publish DateJuly 11, 2024

Melanie Cree, a pediatric endocrinologist at Children’s Hospital Colorado [and associate professor of pediatrics at CU School of Medicine], conducted a randomized trial to test semaglutide, the active ingredient in drugs like Wegovy and Ozempic, in women and adolescents with PCOS.

More News
CPR

Heat stress, heat stroke, and rethinking neighborhoods to stay cool

news outletCPR
Publish DateJuly 11, 2024

Heat kills more people than any other weather-related event in the United States, and with parts of Colorado expecting days of triple-digit weather heading into the weekend, doctors say understanding the risk is essential.

More News
Science

Weight loss drugs without the nausea? Mouse study suggests it may be possible

news outletScience
Publish DateJuly 10, 2024

Millions of people have taken glucagon-like peptide-1 (GLP-1) agonist drugs such as Ozempic to lose weight, despite the fact that the drugs can cause severe nausea and vomiting.

More News